Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: Results of a randomized study of early palliative care

Journal of Clinical Oncology

Volumn 29, Issue 17, 2011, Pages 2319-2326

  Temel, Jennifer S ^a,b,c   Greer, Joseph A ^a,b,c   Admane, Sonal ^a,b,c   Gallagher, Emily R ^a,b,c   Jackson, Vicki A ^a,b,c   Lynch, Thomas J ^a,b,c   Lennes, Inga T ^a,b,c   Dahlin, Connie M ^a,b,c   Pirl, William F ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CONTROLLED STUDY; EARLY INTERVENTION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTATIC LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TERMINAL CARE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; PERCEPTION; PROGNOSIS;

EID: 79959304656     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.4459     Document Type: Article

References (42)

1. Temel JS, Pirl WF, Lynch TJ: Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clinical Lung Cancer 7:241-249, 2006 (Pubitemid 43280026)
2. Lutz S, Norrell R, Bertucio C, et al: Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: A prospective study using the Lung Cancer Symptom Scale in a community hospital. J Palliat Med 4:157-165, 2001 (Pubitemid 32592118)
3. Hopwood P, Stephens RJ: Symptoms at presentation for treatment in patients with lung cancer: Implications for the evaluation of palliative treatment - The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer 71:633-636, 1995
4. Bezjak A, Tu D, Seymour L, et al: Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol 24:3831-3837, 2006 (Pubitemid 46630729)
5. Pirker R, Pereira JR, Szczesna A, et al: Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): An open-label randomised phase III trial. Lancet 373:1525-1531, 2009
6. Scagliotti GV, Parikh P, von Pawel J, et al: Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543-3551, 2008
7. Silvestri G, Pritchard R, Welch HG: Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews. BMJ 317:771-775, 1998 (Pubitemid 28427226)
8. Hirose T, Yamaoka T, Ohnishi T, et al: Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer. Psychooncology 18:483-489, 2009
9. Brundage MD, Davidson JR, Mackillop WJ: Trading treatment toxicity for survival in locally advanced non-small-cell lung cancer. J Clin Oncol 15:330-340, 1997 (Pubitemid 27020591)
10. Fried TR, Bradley EH, Towle VR, et al: Understanding the treatment preferences of seriously ill patients. N Engl J Med 346:1061-1066, 2002 (Pubitemid 34984621)
11. Rose JH, O'Toole EE, Dawson NV, et al: Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 22:4907-4917, 2004 (Pubitemid 46638615)
12. Weeks JC, Cook EF, O'Day SJ, et al: Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714, 1998 (Pubitemid 28247301)
13. Steinhauser KE, Christakis NA, Clipp EC, et al: Preparing for the end of life: Preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage 22:727-737, 2001 (Pubitemid 32776585)
14. Steinhauser KE, Christakis NA, Clipp EC, et al: Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284:2476-2482, 2000
15. Steinhauser KE, Clipp EC, McNeilly M, et al: In search of a good death: Observations of patients, families, and providers. Ann Intern Med 132:825-832, 2000
16. Zhang B, Wright AA, Huskamp HA, et al: Health care costs in the last week of life: Associations with end-of-life conversations. Arch Intern Med 169:480-488, 2009
17. Leighl NB, Shepherd FA, Zawisza D, et al: Enhancing treatment decision-making: Pilot study of a treatment decision aid in stage IV non-small-cell lung cancer. Br J Cancer 98:1769-1773, 2008 (Pubitemid 351748856)
18. Craft PS, Burns CM, Smith WT, et al: Knowledge of treatment intent among patients with advanced cancer: A longitudinal study. Eur J Cancer Care (Engl) 14:417-425, 2005 (Pubitemid 41695944)
19. Back AL, Arnold RM: Discussing prognosis: How much do you want to know? Talking to patients who are prepared for explicit information. J Clin Oncol 24:4209-4213, 2006 (Pubitemid 46622301)
20. Thompson GN, Chochinov HM, Wilson KG, et al: Prognostic acceptance and the well-being of patients receiving palliative care for cancer. J Clin Oncol 27:5757-5762, 2009
21. Hagerty RG, Butow PN, Ellis PM, et al: Communicating with realism and hope: Incurable cancer patients' views on the disclosure of prognosis. J Clin Oncol 23:1278-1288, 2005 (Pubitemid 46202286)
22. Jackson VA, Jacobsen JC, Greer J, et al: Components of early intervention outpatient palliative care consultation in patients with incurable NSCLC. J Clin Oncol 27, 2009 (suppl; abstr e20635)
23. Clinical Practice Guidelines for Quality Palliative Care (ed 2). http://www.nationalconsensusproject.org, 2009
24. Follwell M, Burman D, Le LW, et al: Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 27:206-213, 2009
25. Higginson IJ, Finlay IG, Goodwin DM, et al: Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manage 25:150-168, 2003
26. Jordhøy MS, Fayers P, Loge JH, et al: Quality of life in palliative cancer care: Results from a cluster randomized trial. J Clin Oncol 19:3884-3894, 2001 (Pubitemid 32880067)
27. Bakitas M, Lyons KD, Hegel MT, et al: Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial. JAMA 302:741-749, 2009
28. Meyers FJ, Linder J, Beckett L, et al: Simultaneous care: A model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage 28:548-556, 2004 (Pubitemid 39626099)
29. Rabow MW, Dibble SL, Pantilat SZ, et al: The comprehensive care team: A controlled trial of outpatient palliative medicine consultation. Arch Intern Med 164:83-91, 2004 (Pubitemid 38067393)
30. Temel JS, Jackson VA, Billings JA, et al: Phase II study: Integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol 25:2377-2382, 2007 (Pubitemid 47007615)
31. Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastastic non-small-cell lung cancer. N Engl J Med 363:733-742, 2010
32. Wolf J, Klar N, Grier HE, et al: Understanding of prognosis among parents of children who died of cancer: Impact on treatment goals and integration of palliative care. JAMA 384:2469-2475, 2000
33. Burns CM, Dixon T, Broom D, et al: Family caregiver knowledge of treatment intent in a longitudinal study of patients with advanced cancer. Support Care Cancer 11:629-637, 2003 (Pubitemid 37243593)
34. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002 (Pubitemid 34438899)
35. Sandler A, Gray R, Perry MC, et al: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542-2550, 2006 (Pubitemid 44917502)
36. Kris MG, Natale RB, Herbst RS, et al: Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial. JAMA 290:2149-2158, 2003 (Pubitemid 37432975)
37. Gattellari M, Voigt KJ, Butow PN, et al: When the treatment goal is not cure: Are cancer patients equipped to make informed decisions? J Clin Oncol 20:503-513, 2002
38. Keating NL, Beth Landrum M, Arora NK, et al: Cancer patients' roles in treatment decisions: Do characteristics of the decision influence roles? J Clin Oncol 28:4364-4370, 2010
39. Hanna N, Shepherd FA, Fossella FV, et al: Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589-1597, 2004 (Pubitemid 41079796)
40. Mack JW, Cook EF, Wolfe J, et al: Understanding of prognosis among parents of children with cancer: Parental optimism and the parent-physician interaction. J Clin Oncol 25:1357-1362, 2007 (Pubitemid 46706882)
41. Mack JW, Wolfe J, Cook EF, et al: Hope and prognostic disclosure. J Clin Oncol 25:5636-5642, 2007
42. Mack JW, Wolfe J, Grier HE, et al: Communication about prognosis between parents and physicians of children with cancer: Parent preferences and the impact of prognostic information. J Clin Oncol 24:5265-5270, 2006 (Pubitemid 46631372)